Diversity of T Cell Epitopes in Plasmodium falciparum Circumsporozoite Protein Likely Due to Protein-Protein Interactions

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Aragam, Nagesh R ^a   Thayer, Kelly M ^b   Nge, Nabi ^c   Hoffman, Irving ^a   Martinson, Francis ^d   Kamwendo, Debbie ^d   Lin, Feng Chang ^e   Sutherland, Colin ^c   Bailey, Jeffrey A ^b   Juliano, Jonathan J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^e IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; EPITOPE; TH2 EPITOPE; TH3 EPITOPE; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN RECOGNITION; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENERGY METABOLISM; GAMBIA; GENETIC DISTANCE; GENETIC POLYMORPHISM; HYDROPHOBICITY; MALAWI; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POINT MUTATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; EPITOPES, T-LYMPHOCYTE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PHYLOGENY; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTEIN CONFORMATION; PROTOZOAN PROTEINS;

EID: 84877105578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062427     Document Type: Article

References (40)

1. Waitumbi JN, Anyona SB, Hunja CW, Kifude CM, Polhemus ME, et al. (2009) Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS ONE 4: e7849 doi:10.1371/journal.pone.0007849.
2. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, et al. (2011) First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 365: 1863-1875 doi:10.1056/NEJMoa1102287.
3. Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BGNO, et al. (2012) A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 367: 2284-2295 doi:10.1056/NEJMoa1208394.
4. Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, et al. (2009) Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med 1: 2ra5 doi:10.1126/scitranslmed.3000257.
5. Bailey JA, Mvalo T, Aragam N, Weiser M, Congdon S, et al. (2012) Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi. J Infect Dis 206: 580-587 doi:10.1093/infdis/jis329.
6. Alloueche A, Milligan P, Conway DJ, Pinder M, Bojang K, et al. (2003) Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hyg 68: 97-101.
7. Hoffman SL, Oster CN, Mason C, Beier JC, Sherwood JA, et al. (1989) Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 142: 1299-1303.
8. Good MF, Pombo D, Quakyi IA, Riley EM, Houghten RA, et al. (1988) Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci USA 85: 1199-1203.
9. Riley EM, Allen SJ, Bennett S, Thomas PJ, O'Donnell A, et al. (1990) Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. Trans R Soc Trop Med Hyg 84: 648-657.
10. Good MF, Berzofsky JA, Miller LH, (1988) The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol 6: 663-688 doi:10.1146/annurev.iy.06.040188.003311.
11. Hughes AL, (1991) Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regions. Genetics 127: 345-353.
12. Jongwutiwes S, Tanabe K, Hughes MK, Kanbara H, Hughes AL, (1994) Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. Am J Trop Med Hyg 51: 659-668.
13. Weedall GD, Preston BMJ, Thomas AW, Sutherland CJ, Conway DJ, (2007) Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens. Int J Parasitol 37: 77-85 doi:10.1016/j.ijpara.2006.09.001.
14. Gonzalez-Ceron L, Rodriguez MH, Nettel JC, Villarreal C, Kain KC, et al. (1999) Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico. Infect Immun 67: 410-412.
15. Kumkhaek C, Phra-Ek K, Rénia L, Singhasivanon P, Looareesuwan S, et al. (2005) Are extensive T cell epitope polymorphisms in the Plasmodium falciparum circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? J Immunol 175: 3935-3939.
16. Ménard R, Sultan AA, Cortes C, Altszuler R, Van Dijk MR, et al. (1997) Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature 385: 336-340 doi:10.1038/385336a0.
17. Stewart MJ, Vanderberg JP, (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35: 389-393.
18. Barry AE, Schultz L, Buckee CO, Reeder JC, (2009) Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS ONE 4: e8497 doi:10.1371/journal.pone.0008497.
19. Doud MB, Koksal AC, Mi L-Z, Song G, Lu C, et al. (2012) Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc Natl Acad Sci USA 109: 7817-7822 doi:10.1073/pnas.1205737109.
20. Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, et al. (2007) Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J Infect Dis 196: 1613-1619 doi:10.1086/522154.
21. Sutherland CJ, Drakeley CJ, Obisike U, Coleman R, Jawara M, et al. (2003) The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Am J Trop Med Hyg 69: 19-25.
22. DNASTAR Inc. (2008) Sequence analysis using DNASTAR's Lasergene Software Suite. Madison, WI, USA.
23. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452 doi:10.1093/bioinformatics/btp187.
24. Excoffier L, Laval G, Schneider S, (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.
25. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739 doi:10.1093/molbev/msr121.
26. Hudson RR, (2000) A new statistic for detecting genetic differentiation. Genetics 155: 2011-2014.
27. Agresti A (2007) An Introduction to Categorical Data Analysis. 2nd ed. Wiley-Interscience. 400 p.
28. Publishing SAS (2010) SAS 9.2 Language Reference: Dictionary, Third Edition. 3rd ed. SAS Publishing. 2328 p.
29. Schneider TD, Stephens RM, (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18: 6097-6100.
30. Crooks GE, Hon G, Chandonia J-M, Brenner SE, (2004) WebLogo: a sequence logo generator. Genome Res 14: 1188-1190 doi:10.1101/gr.849004.
31. Stiebritz MT, Muller YA, (2006) MUMBO: a protein-design approach to crystallographic model building and refinement. Acta Crystallogr D Biol Crystallogr 62: 648-658 doi:10.1107/S0907444906013333.
32. Brooks BR, Brooks CL 3rd, Mackerell AD Jr, Nilsson L, Petrella RJ, et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545-1614 doi:10.1002/jcc.21287.
33. Takala SL, Plowe CV, (2009) Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming "vaccine resistant malaria". Parasite Immunol 31: 560-573 doi:10.1111/j.1365-3024.2009.01138.x.
34. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, et al. (2011) A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365: 1004-1013 doi:10.1056/NEJMoa1008115.
35. Enosse S, Dobaño C, Quelhas D, Aponte JJ, Lievens M, et al. (2006) RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials 1: e5 doi:10.1371/journal.pctr.0010005.
36. Alloueche A, Silveira H, Conway DJ, Bojang K, Doherty T, et al. (2000) High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. Mol Biochem Parasitol 106: 273-282.
37. Sinnis P, Clavijo P, Fenyö D, Chait BT, Cerami C, et al. (1994) Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med 180: 297-306.
38. Rathore D, McCutchan TF, (2000) Role of cysteines in Plasmodium falciparum circumsporozoite protein: interactions with heparin can rejuvenate inactive protein mutants. Proc Natl Acad Sci USA 97: 8530-8535 doi:10.1073/pnas.140224597.
39. Cerami C, Frevert U, Sinnis P, Takacs B, Clavijo P, et al. (1992) The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell 70: 1021-1033.
40. Chenet SM, Branch OH, Escalante AA, Lucas CM, Bacon DJ, (2008) Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Malar J 7: 93 doi:10.1186/1475-2875-7-93.